Institute for Neurodegenerative Disorders   Report issue

Foundation Phase 1 Phase 2
Founded: New Haven CT United States (2001)

Organization Overview

First Clinical Trial
2001
NCT00132626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Institute for Neurodegenerative Disorders | The Institute for Neurodegenerative Disorders